168官方网站®幸运168查询-中国飞行艇历史记录+开奖记录结果查询,实时结果直播走势

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

May 11, 2026

168飞艇开奖结果查询记录+最新号码查询今天幸运168官方开奖历史记录网-Supreme Court temporarily extends women’s access to a widely used abortion pill
May 11, 2026

STAT Plus: Colombia wins a key court ruling over a compulsory license issued for an HIV medicine
May 11, 2026

STAT Plus: Trump pivots on kratom derivative 7-OH, floating approval for some forms
May 11, 2026

STAT Plus: Medicare’s miss on Alzheimer’s drug spending
May 11, 2026

No FDA permission, no problem: New flavored vape policy worries experts
May 11, 2026

What addiction medicine can teach us about depending on AI

More Stories

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

Nominate a 2026 STAT Wunderkind now!

STAT Plus: Five years after disaster, a rare disease community gets new chance at treatment

Astellas renews trials of gene therapy for XLMTM, hoping for success stories like JJ’s

Health May 11, 2026

168网体彩中国查询记录历史-查询幸运飞开艇168®(中国福彩)官网直播结果历史,记录号码走势-Animal skin disease confirmed in clusters of European men who have sex with men

Exclusive May 11, 2026

STAT Plus: Medicare is spending far less than expected on new Alzheimer’s drugs

Politics May 11, 2026

STAT Plus: Provider, insurer groups rush to shape No Surprises Act arbitration rules

First Opinion May 11, 2026

AI doctors should be licensed. Here’s a framework to do that

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

Subscribe now

STAT Plus: Medicare is spending far less than expected on new Alzheimer’s drugs

STAT Plus: Five years after disaster, a rare disease community gets new chance at treatment

STAT Plus: Roche to buy PathAI for $750 million

STAT Plus: Provider, insurer groups rush to shape No Surprises Act arbitration rules

STAT Plus: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

2026 Breakthrough Summit West

San Francisco, CA

Spotlighting the science and technology shaping the future of health and medical innovation.

STAT@ASCO: Science vs. Cancer

Chicago, IL

ASCO 2026: The STAT Recap

Virtual

2026 STAT Summit

Boston, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Chaotic and politicized: Inside the FDA under Trump

$49

Explore how turmoil and political pressure have destabilized the agency with mass layoffs, rapid staff departures, and a revolving door of leadership.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

168体彩网查询开奖官网®幸运168飞艇-飞行艇历史记录查询-中国体彩168开奖查询记录结果 More Stories

Politics May 11, 2026

Supreme Court temporarily extends women’s access to a widely used abortion pill

Pharmalot May 11, 2026

STAT Plus: Colombia wins a key court ruling over a compulsory license issued for an HIV medicine

Health May 11, 2026

STAT Plus: Trump pivots on kratom derivative 7-OH, floating approval for some forms

Health Care Inc. Newsletter May 11, 2026

STAT Plus: Medicare’s miss on Alzheimer’s drug spending

Health May 11, 2026

No FDA permission, no problem: New flavored vape policy worries experts

First Opinion May 11, 2026

What addiction medicine can teach us about depending on AI

Health May 9, 2026

Experts wonder ‘Where is the CDC?’ as hantavirus outbreak unfolds

First Opinion Podcast May 9, 2026

Dr. Glaucomflecken wants the corporatization of medicine to be national news

First Opinion May 9, 2026

RFK Jr. allegedly ‘collected’ a dead raccoon’s penis. Was it bioethically justifiable?

Health May 8, 2026

Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islands

Health tech May 8, 2026

STAT Plus: Roche to buy PathAI for $750 million

Politics May 8, 2026

Trump reportedly plans to fire FDA Commissioner Makary

All Stories

The Readout May 11, 2026

STAT Plus: Astellas treatment offers new hope to a devastated rare disease community

Pharmalot May 11, 2026

STAT Plus: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and more

Pharmalot May 8, 2026

STAT Plus: Up and down the ladder: The latest comings and goings

The Readout May 8, 2026

STAT Plus: The biotech news you need to read today

Pharmalot May 8, 2026

STAT Plus: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more

Opinions+ May 8, 2026

STAT Plus: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting

First Opinion May 11, 2026

What addiction medicine can teach us about depending on AI

First Opinion May 11, 2026

AI doctors should be licensed. Here’s a framework to do that

First Opinion May 9, 2026

RFK Jr. allegedly ‘collected’ a dead raccoon’s penis. Was it bioethically justifiable?

First Opinion Podcast May 9, 2026

Dr. Glaucomflecken wants the corporatization of medicine to be national news

First Opinion May 8, 2026

I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook

First Opinion May 8, 2026

We need more men in nursing

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with

By Andrew Joseph

STAT Plus: Ambiguous loss: a peculiar kind of grief in dementia care

By Jason Karlawish

STAT Plus: What was lost at the FDA

By Lizzy Lawrence

What happened to Covid?

By Helen Branswell

Securing NIH awards is getting more competitive — and confusing

Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood

By Matthew Herper

Even for trans adults, care is hard to find: ‘I could not do it on my own’

By Theresa Gaffney

Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush

The biotechs wear Prada

Biotech May 8, 2026

The biotechs wear Prada

Biotech May 7, 2026

STAT Plus: FDA to reconsider treatment for rare cancer after its surprise rejection

Biotech May 7, 2026

STAT Plus: Next-gen Duchenne drug from Entrada disappoints

STAT Plus: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more

Pharmalot May 7, 2026

STAT Plus: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more

Pharmalot May 6, 2026

STAT Plus: Pharmalittle: We’re reading about a PhRMA ad campaign aimed at 340B, sales of Novo’s obesity pill, and more

Pharmalot May 5, 2026

STAT Plus: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing

Key takeaways from WHO briefing on hantavirus cruise ship outbreak

Health May 7, 2026

Key takeaways from WHO briefing on hantavirus cruise ship outbreak

Health May 7, 2026

Cruise ship hantavirus outbreak worries experts, though they discount pandemic fears

Health May 6, 2026

Trump administration’s drug strategy is at odds with recent actions on funding, policy

Former FDA leaders, pharma speak out on mifepristone

Politics May 8, 2026

Former FDA leaders, pharma speak out on mifepristone

Politics May 6, 2026

STAT Plus: Administration report on most favored nation drug pricing raises new details — and questions

Politics May 5, 2026

STAT Plus: Top lawmaker takes aim at doctor lobby, linking AMA’s billing codes to fraud fight

Video

Why we left the FDA: Six former officials share their stories

Psychedelics get a boost from the White House

Robert F. Kennedy Jr. testifies before Senate HELP committee

How sports betting apps hook users

All Videos

STAT Plus: OpenAI wants to ‘have their cake and eat it too’ with health AI policy recommendations

Health tech May 6, 2026

STAT Plus: OpenAI wants to ‘have their cake and eat it too’ with health AI policy recommendations

Health tech April 30, 2026

STAT Plus: As artificial intelligence shows off diagnostic chops, scientists reckon with the way forward

Health tech April 28, 2026

STAT Plus: Google clinical director says AI can be a ‘bridge’ for people having a mental health crisis

Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers

In the Lab May 7, 2026

Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers

In the Lab May 7, 2026

Science is becoming less disruptive. Is an aging workforce to blame?

In the Lab May 6, 2026

STAT Plus: How a global effort to explore the ‘dark proteome’ is upending our understanding of human disease

STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital

Hospitals April 14, 2026

STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital

Hospitals March 13, 2026

STAT Plus: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality

Hospitals March 10, 2026

STAT Plus: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again

STAT Plus: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case

Insurance April 30, 2026

STAT Plus: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case

Insurance February 16, 2026

STAT Plus: Medicare Advantage growth dwindles for a second straight year

Insurance February 9, 2026

STAT Plus: Federal government turns to fresher data to rein in Medicare Advantage upcoding

Podcasts

STAT Plus: Hair-raising trial results, and Servier’s M&A wishlist

A new trick for old science, and biotech VCs’ scrambled playbook

How sports betting is hooking some young men

Biotech investors’ plea to Trump, and a busy M&A week

All Podcasts